Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William Stainier

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
The Journal of Experimental Medicine|November 13, 2025
AC/DC: Highway to cellVictor Bosteels, William Stainier, Caetano Reis E Sousa
Nature Cell Biology|July 4, 2024
Direct observation of translational activation by a ribonucleoprotein granuleRuoyu Chen, William Stainier, Jeremy Dufourt, et al.
The EMBO Journal|October 30, 2025
DNGR-1 signalling limits dendritic cell activation for optimal antigen cross-presentationMichael D Buck, Tomás Castro-Dopico, Oliver Schulz, et al.
Nature Immunology|January 2, 2026
Cross-presentation of dead cell-associated antigens shapes the neoantigenic landscape of tumor immunityKok Haw Jonathan Lim, Oliver Schulz, Irene Lobon, et al.
Nature Cancer|May 20, 2026
Coupling dead cell recognition to Fcγ receptors augments anticancer immunityTomás Castro-Dopico, Cécile Piot, Michael D Buck, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
The Journal of Experimental Medicine|November 13, 2025
AC/DC: Highway to cellVictor Bosteels, William Stainier, Caetano Reis E Sousa
Nature Cell Biology|July 4, 2024
Direct observation of translational activation by a ribonucleoprotein granuleRuoyu Chen, William Stainier, Jeremy Dufourt, et al.
The EMBO Journal|October 30, 2025
DNGR-1 signalling limits dendritic cell activation for optimal antigen cross-presentationMichael D Buck, Tomás Castro-Dopico, Oliver Schulz, et al.
Nature Immunology|January 2, 2026
Cross-presentation of dead cell-associated antigens shapes the neoantigenic landscape of tumor immunityKok Haw Jonathan Lim, Oliver Schulz, Irene Lobon, et al.
Nature Cancer|May 20, 2026
Coupling dead cell recognition to Fcγ receptors augments anticancer immunityTomás Castro-Dopico, Cécile Piot, Michael D Buck, et al.
Pageof 1